These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1786494)

  • 1. Drug metabolism and interactions in abuse liability assessment.
    Sellers EM; Otton SV; Busto UE
    Br J Addict; 1991 Dec; 86(12):1607-14. PubMed ID: 1786494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic considerations in abuse liability evaluation.
    Farré M; Camí J
    Br J Addict; 1991 Dec; 86(12):1601-6. PubMed ID: 1786493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic and pharmacodynamic drug interactions: implications for abuse liability testing.
    Sellers EM; Busto U; Kaplan HL
    NIDA Res Monogr; 1989; 92():287-306. PubMed ID: 2512498
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug discrimination methods in human drug abuse liability evaluation.
    Preston KL
    Br J Addict; 1991 Dec; 86(12):1587-94. PubMed ID: 1786491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug self-administration methods in abuse liability evaluation.
    Henningfield JE; Cohen C; Heishman SJ
    Br J Addict; 1991 Dec; 86(12):1571-7. PubMed ID: 1786489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance and physiological measures in abuse liability evaluation.
    Roache JD
    Br J Addict; 1991 Dec; 86(12):1595-600. PubMed ID: 1786492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of participants and experimental design in clinical abuse liability testing.
    Mendelson JH
    Br J Addict; 1991 Dec; 86(12):1543-8. PubMed ID: 1786485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of subjective-effects measurements in assessing abuse liability of drugs in humans.
    Fischman MW; Foltin RW
    Br J Addict; 1991 Dec; 86(12):1563-70. PubMed ID: 1786488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspectives and future on testing for abuse liability in humans.
    Camí J
    Br J Addict; 1991 Dec; 86(12):1529-31. PubMed ID: 1786482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing abuse liability during drug development: changing standards and expectations.
    Schoedel KA; Sellers EM
    Clin Pharmacol Ther; 2008 Apr; 83(4):622-6. PubMed ID: 18212799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug abuse potential evaluation in animals.
    Balster RL
    Br J Addict; 1991 Dec; 86(12):1549-58. PubMed ID: 1786486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preference procedures for testing the abuse liability of drugs in humans.
    De Wit H
    Br J Addict; 1991 Dec; 86(12):1579-86. PubMed ID: 1786490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation and abuse liability testing of medicines in Europe beyond 1992.
    García Alonso F
    Br J Addict; 1991 Dec; 86(12):1533-6. PubMed ID: 1786483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacologic interactions of antibiotics and psychotropic drugs].
    Joos AA
    Psychiatr Prax; 1998 Mar; 25(2):57-60. PubMed ID: 9577846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acting out and psychoactive substances: alcohol, drugs, illicit substances].
    Gillet C; Polard E; Mauduit N; Allain H
    Encephale; 2001; 27(4):351-9. PubMed ID: 11686057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Principles of initial experimental drug abuse liability assessment in humans.
    Griffiths RR; Bigelow GE; Ator NA
    Drug Alcohol Depend; 2003 Jun; 70(3 Suppl):S41-54. PubMed ID: 12759196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying appropriate subjects for abuse liability studies using prestudy pharmacological testing.
    Busto UE; Zawertailo LA; Kaplan HL; Sellers EM
    Can J Clin Pharmacol; 1999; 6(2):103-10. PubMed ID: 10519736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using drug-discrimination techniques to study the abuse-related effects of psychoactive drugs in rats.
    Solinas M; Panlilio LV; Justinova Z; Yasar S; Goldberg SR
    Nat Protoc; 2006; 1(3):1194-206. PubMed ID: 17406402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical significance of pharmacogenetics in psychiatry].
    Skrętkowicz J; Barańska M; Rychlik-Sych M
    Wiad Lek; 2013; 66(2 Pt 2):185-91. PubMed ID: 25775815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Abuse of psychotropic drugs during driving].
    Lemoine P; Ohayon M
    Encephale; 1996; 22(1):1-6. PubMed ID: 8681870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.